Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Estcourt

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Transfusion Medicine (Oxford, England)|March 13, 2019
Platelet transfusion thresholds in premature neonates (PlaNeT-2 trial)L J Estcourt
Transfusion Medicine (Oxford, England)|July 19, 2019
Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura (HERCULES trial)L J Estcourt
Transfusion Medicine (Oxford, England)|October 21, 2014
Why has demand for platelet components increased? A reviewL J Estcourt
Transfusion Medicine (Oxford, England)|April 12, 2019
Six-month outcomes after restrictive or liberal transfusion for cardiac surgery (TRICS III trial)L J Estcourt, D J Roberts
Vox Sanguinis|July 11, 2012
Platelet transfusions in haematology patients: are we using them appropriately?L J Estcourt, J Birchall, D Lowe, et al.
Journal of Thrombosis and Haemostasis : JTH|November 29, 2016
Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trialsM J R Desborough, K A Oakland, G Landoni, et al.
Vox Sanguinis|January 11, 2018
A multicentred study to validate a consensus bleeding assessment tool developed by the biomedical excellence for safer transfusion collaborative for use in patients with haematological malignancyC Dyer, C R Alquist, M Cole-Sinclair, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Transfusion Medicine (Oxford, England)|March 13, 2019
Platelet transfusion thresholds in premature neonates (PlaNeT-2 trial)L J Estcourt
Transfusion Medicine (Oxford, England)|July 19, 2019
Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura (HERCULES trial)L J Estcourt
Transfusion Medicine (Oxford, England)|October 21, 2014
Why has demand for platelet components increased? A reviewL J Estcourt
Transfusion Medicine (Oxford, England)|April 12, 2019
Six-month outcomes after restrictive or liberal transfusion for cardiac surgery (TRICS III trial)L J Estcourt, D J Roberts
Vox Sanguinis|July 11, 2012
Platelet transfusions in haematology patients: are we using them appropriately?L J Estcourt, J Birchall, D Lowe, et al.
Journal of Thrombosis and Haemostasis : JTH|November 29, 2016
Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trialsM J R Desborough, K A Oakland, G Landoni, et al.
Vox Sanguinis|January 11, 2018
A multicentred study to validate a consensus bleeding assessment tool developed by the biomedical excellence for safer transfusion collaborative for use in patients with haematological malignancyC Dyer, C R Alquist, M Cole-Sinclair, et al.
Pageof 1